Acasti Pharma Forecast and Stock Analysis
Technical ACST stock analysis for March 25, 2019.
No changes to the price of Acasti Pharma in the last trading day. The price has risen in 4 of the last 10 days and is up by 1.94% over the past 2 weeks.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the ACST stock was $1.05.
During day the stock fluctuated 4.93% from a day low at $1.00 to a day high of $1.05.
30 day high of the ACST stock price was $1.12 and low was $0.99.
90 day high was $1.15 and low was $0.66.
52 week high for the Acasti Pharma - $1.80 and low - $0.43.
Acasti Pharma lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.3% during the next 3 months and, with 90% probability hold a price between $1.06 and $1.42 at the end of this period.
Acasti Pharma holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.06. On a fall, the stock will find some support from the long-term average at approximately $1.02. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Friday March 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".
Relative Strength Index (RSI)
RSI14 is 48 and the stock is currently not being overbought or oversold
Support & Resistance
Acasti Pharma finds support from accumulated volume at $1.03.
In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.
Our recommended stoploss: $0.98 (-6.28%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.